Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Lands $2.2M DoD Contract for Array-based Biothreat Dx

NEW YORK (GenomeWeb News) - The US Department of Defense has awarded CombiMatrix a one-year, $2.2 million contract to continue developing its microarrays to detect pathogens and toxins for use in bio-terror defense, CombiMatrix said today.
 
The company said under earlier DoD-funded programs it “demonstrated that its products can “simultaneously detect toxins, viruses, and bacteria using its semiconductor-based microarrays.”
 
In October 2006, CombiMatrix won two million-dollar allocations under the 2007 Defense Appropriations Bill to develop these technologies, including a micoarray for the H5N1 avian influenza virus.
 
Last May, the company won a sub-contract for an undisclosed sum from Northrup Grummon to help develop a handheld sensor to detect bio-threats for the Defense Advanced Research Projects Agency.
 
The company is designing products to address biothreat agents as well as infectious diseases “of public-health concern,” including influenza A and the avian flu subtype David Danley, director of homeland security and defense programs at CombiMatrix, said in a statement.
 
The company added that its devices using its electrochemical-based detection systems are already being used “at several military and government laboratories as well as civilian installations.”
 
CombiMatrix CEO Amit Kumar said the DoD contract “fits nicely with our strategy of developing products for the molecular-diagnostics and the personalized-medicine market segments.”

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.